Skoči na glavni sadržaj

ADMET and DMPK , Vol. 4 No. 4, 2016.

  • Datum izdavanja: 26.12.2016.
  • Objavljen na Hrčku: 26.12.2016.

Sadržaj

Puni tekst

ROCK inhibitors in ocular disease (str. 280-301)

Éva Halász, Ellen Townes-Anderson
Pregledni rad

engleski pdf 724kb
Tyrosine and aurora kinase inhibitors diminish transport function of multidrug resistance-associated protein (MRP) 4 and breast cancer resistance protein (BCRP) (str. 302-313)

Rhiannon N. Hardwick, Marina Snellings, Brian C. Ferslew, Yang Lu, Kim L.R. Brouwer
Izvorni znanstveni članak

engleski pdf 831kb
Preclinical formulation for the pharmacokinetics and efficacy of GBO-006, a selective polo like kinase 2 (PLK2) inhibitor for the treatment of triple negative breast cancer (str. 314-326)

Srinivas Maddi, Ravi Akkireddy, Srinivas Lenkalapelly, Pratima Srivastava, Joshodeep Boruwa, Chandra Deb, Arnab Roy Chowdhury, Duraiswamy A. Jeyaraj, Ramana Reddy, Premkumar Reddy, Manoj Maniar, Sachin Bansal, Jang B. Gupta
Izvorni znanstveni članak

engleski pdf 574kb
Tissue distribution of crizotinib and gemcitabine combination in a patient-derived orthotopic mouse model of pancreatic cancer (str. 327-334)

Richard J Honeywell, Amir Avan, Elisa Giovannetti, Godefridus J Peters
Izvorni znanstveni članak

engleski pdf 494kb
Investigation of biopharmaceutical and physicochemical drug properties suitable for orally disintegrating tablets (str. 335-360)

Asami Ono, Takumi Tomono, Takuo Ogihara, Katsuhide Terada, Kiyohiko Sugano
Izvorni znanstveni članak

engleski pdf 1213kb

Posjeta: 27.274 *